Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis

[1]  R. Buchanan,et al.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models. , 2015, Schizophrenia bulletin.

[2]  S. Djurovic,et al.  Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. , 2014, Journal of psychiatric research.

[3]  A. Boyajyan,et al.  Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes. , 2014, Clinical biochemistry.

[4]  P. Chen,et al.  The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  M. Webster,et al.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders , 2014, Translational Psychiatry.

[6]  Norio Sugawara,et al.  Preanalysis Storage Conditions Influence the Measurement of Brain-Derived Neurotrophic Factor Levels in Peripheral Blood , 2014, Neuropsychobiology.

[7]  Anthony O Ahmed,et al.  Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets , 2014, CNS Drugs.

[8]  Daniel J Fridberg,et al.  Brain-derived neurotrophic factor and neurocognitive profiles in the psychosis spectrum: Findings in bipolar disorder and schizophrenia , 2013 .

[9]  E. Tongiorgi,et al.  Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions? , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[10]  B. Kolachana,et al.  Effects of the BDNF Val66Met Polymorphism on White Matter Microstructure in Healthy Adults , 2013, Neuropsychopharmacology.

[11]  F. Kapczinski,et al.  Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis , 2013, BMC Psychiatry.

[12]  C. Tai,et al.  Psychiatric disorders of patients seeking obesity treatment , 2013, BMC Psychiatry.

[13]  M. Pedrini,et al.  Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: A study in adolescent rats with ketamine-induced model of schizophrenia , 2012, Schizophrenia Research.

[14]  D. Collier,et al.  Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis , 2012, Neuroscience & Biobehavioral Reviews.

[15]  R. McIntyre,et al.  A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  R. Murray,et al.  BDNF gene polymorphism, cognition and symptom severity in a Brazilian population-based sample of first-episode psychosis subjects. , 2012, Revista brasileira de psiquiatria.

[17]  P. Buckley,et al.  Reliable biomarkers and predictors of schizophrenia and its treatment. , 2012, The Psychiatric clinics of North America.

[18]  Chen Zhang,et al.  Association Between BDNF Val66Met Polymorphism and Cognitive Performance in Antipsychotic-Naïve Patients with Schizophrenia , 2012, Journal of Molecular Neuroscience.

[19]  P. Buckley,et al.  Taxometric analyses of paranoid and schizoid personality disorders , 2012, Psychiatry Research.

[20]  A. Veronica Witte,et al.  Interaction of BDNF and COMT Polymorphisms on Paired-Associative Stimulation-Induced Cortical Plasticity , 2012, The Journal of Neuroscience.

[21]  Margaret L. Schlichting,et al.  The hippocampus and inferential reasoning: building memories to navigate future decisions , 2012, Front. Hum. Neurosci..

[22]  E. Grigorenko,et al.  BDNF Val66Met and cognition: all, none, or some? A meta‐analysis of the genetic association , 2012, Genes, brain, and behavior.

[23]  E. Koechlin,et al.  Reasoning, Learning, and Creativity: Frontal Lobe Function and Human Decision-Making , 2012, PLoS biology.

[24]  Zhijun Zhang,et al.  Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls , 2012, Human Genetics.

[25]  W. Honer,et al.  Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis , 2012, Schizophrenia Research.

[26]  T. Kosten,et al.  Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia , 2012, Psychopharmacology.

[27]  L. Klei,et al.  Principal Components of Heritability From Neurocognitive Domains Differ Between Families With Schizophrenia and Control Subjects , 2012, Schizophrenia bulletin.

[28]  P. Buckley,et al.  Latent structure of psychotic experiences in the general population , 2012, Acta psychiatrica Scandinavica.

[29]  A. Aleman,et al.  BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity , 2012, Translational Psychiatry.

[30]  D. Matsuzawa,et al.  Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  Shane M. O'Mara,et al.  Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males , 2011, Physiology & Behavior.

[32]  Melissa J. Green,et al.  Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis , 2011, Molecular Psychiatry.

[33]  H. Möller,et al.  Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. , 2011, Schizophrenia bulletin.

[34]  T. Schneider-Axmann,et al.  Eur Arch Psychiatry Clin Neurosci (2012) 262:23–31 DOI 10.1007/s00406-011-0214-6 ORIGINAL PAPER , 2022 .

[35]  E. Tongiorgi,et al.  Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. , 2011, Journal of psychiatric research.

[36]  R. Yoshimura,et al.  Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls , 2011, European Psychiatry.

[37]  S. Lawrie,et al.  Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task , 2010, Psychiatry Research: Neuroimaging.

[38]  J. Kleinman,et al.  Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia , 2010, Neuroscience.

[39]  R. Kahn,et al.  Effects of brain‐derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia , 2010, Hippocampus.

[40]  P. Muglia,et al.  Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. , 2010, Journal of affective disorders.

[41]  Seockhoon Chung,et al.  Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients. , 2010, Comprehensive psychiatry.

[42]  Toshiko Tanaka,et al.  BDNF Val66Met is Associated with Introversion and Interacts with 5-HTTLPR to Influence Neuroticism , 2010, Neuropsychopharmacology.

[43]  J. Baraban,et al.  Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation , 2009, Proceedings of the National Academy of Sciences.

[44]  Sophia Vinogradov,et al.  Is Serum Brain-Derived Neurotrophic Factor a Biomarker for Cognitive Enhancement in Schizophrenia? , 2009, Biological Psychiatry.

[45]  A. Ogura,et al.  Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival , 2009, Molecular Brain.

[46]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[47]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[48]  Jee-Yin Ahn,et al.  Neuroprotection by NGF and BDNF Against Neurotoxin-Exerted Apoptotic Death in Neural Stem Cells Are Mediated Through Trk Receptors, Activating PI3-Kinase and MAPK Pathways , 2009, Neurochemical Research.

[49]  S. Yamawaki,et al.  Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. , 2009, The international journal of neuropsychopharmacology.

[50]  K. Heese,et al.  Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. , 2009, Current neurovascular research.

[51]  I. Myin-Germeys,et al.  Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. , 2008, Schizophrenia bulletin.

[52]  Chang Yoon Kim,et al.  Brain-Derived Neurotrophic Factor Val/Met Polymorphism and Bipolar Disorder , 2008, Neuropsychobiology.

[53]  P Rabbitt,et al.  Brain‐derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly , 2008, Genes, brain, and behavior.

[54]  Y. Kawasaki,et al.  Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons , 2008, Neuroscience Letters.

[55]  M. Leboyer,et al.  Interaction between BDNF Val66Met and childhood trauma on adult’s violent suicide attempt , 2008, Genes, brain, and behavior.

[56]  Hongwei Song,et al.  The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[57]  Jeffrey D Dawson,et al.  Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. , 2007, The American journal of psychiatry.

[58]  Bryan L Roth,et al.  Molecular targets for treating cognitive dysfunction in schizophrenia. , 2007, Schizophrenia bulletin.

[59]  Tamara Aid,et al.  Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters☆ , 2007, Genomics.

[60]  Peter F. Buckley,et al.  Neurotrophins and schizophrenia , 2007, Schizophrenia Research.

[61]  Jonathan P Roiser,et al.  Cognitive heterogeneity in schizophrenia , 2007, Current opinion in psychiatry.

[62]  J. González,et al.  Brain-Derived Neurotrophic Factor Val66Met and Psychiatric Disorders: Meta-Analysis of Case-Control Studies Confirm Association to Substance-Related Disorders, Eating Disorders, and Schizophrenia , 2007, Biological Psychiatry.

[63]  P. Buckley,et al.  Brain derived neurotropic factor in first-episode psychosis , 2007, Schizophrenia Research.

[64]  Jiing-Feng Lirng,et al.  The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression , 2006, Neurobiology of Aging.

[65]  Harukazu Tsuruta,et al.  Development and validation of MIX: comprehensive free software for meta-analysis of causal research data , 2006, BMC medical research methodology.

[66]  C. Siao,et al.  Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.

[67]  R. Paz,et al.  Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. , 2006, The American journal of psychiatry.

[68]  T. Wassink,et al.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. , 2006, Archives of general psychiatry.

[69]  Y. Kaneda,et al.  Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms , 2006, Neuroscience Letters.

[70]  J. Savitz,et al.  The molecular genetics of cognition: dopamine, COMT and BDNF , 2006, Genes, brain, and behavior.

[71]  L. Fañanás,et al.  The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family‐based association study , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[72]  Joanna Hauser,et al.  Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain‐derived neurotrophic factor gene , 2006, Psychiatry and clinical neurosciences.

[73]  Barbara L. Hempstead,et al.  ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTR and Sortilin , 2005, The Journal of Neuroscience.

[74]  C. Crombie,et al.  BDNF gene is a risk factor for schizophrenia in a Scottish population , 2005, Molecular Psychiatry.

[75]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[76]  A. Harris,et al.  Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics. , 2004, The Australian and New Zealand journal of psychiatry.

[77]  Paresh D Patel,et al.  Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons , 2004, The Journal of Neuroscience.

[78]  S. Tsai,et al.  Association Study of a Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Personality Trait and Intelligence in Healthy Young Females , 2004, Neuropsychobiology.

[79]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[80]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[81]  W. Grove.  When is a diagnosis worth making? A statistical comparison of two prediction strategies. , 1991, Psychological reports.

[82]  P. Buckley,et al.  Does a latent class underlie schizotypal personality disorder? Implications for schizophrenia. , 2013, Journal of abnormal psychology.

[83]  B. Puri,et al.  Evidence for an association between brain-derived neurotrophic factor Val66Met gene polymorphism and general intellectual ability in early-onset schizophrenia. , 2012, The Israel journal of psychiatry and related sciences.

[84]  R. Lu,et al.  Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia? , 2009, The Journal of neuropsychiatry and clinical neurosciences.

[85]  R. Grissom,et al.  Effect sizes for research: A broad practical approach. , 2005 .

[86]  M. Gratacós,et al.  Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type , 2003, Molecular Psychiatry.

[87]  Kazuhisa Niki,et al.  Function of hippocampus in “insight” of problem solving , 2003, Hippocampus.

[88]  J. Kleinman,et al.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.

[89]  Michael F. Green,et al.  Should Schizophrenia Be Treated as a Neurocognitive Disorder , 1999 .

[90]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .